The complaint, Wistisen v. Alibaba Group Holding Limited, accuses executives of concealing the company’s ties to the Chinese Ministry of Industry and Information Technology. Plaintiffs claim these omissions left investors vulnerable when the U.S. Department of Defense officially designated Alibaba as a Chinese military company under the National Defense Authorization Act on June 8, 2026. This disclosure triggered a 3.9% drop in share price over two trading sessions.
Beyond regulatory exposure, the lawsuit highlights allegations of corporate misconduct involving Anthropic’s Claude AI models. Reports suggest Alibaba used thousands of fraudulent accounts to perform unauthorized distillation attacks to train its own systems. Following the revelation of these practices on June 24, 2026, Alibaba’s stock fell an additional 4.7%. Reed Kathrein, a partner at Hagens Berman, stated the firm is investigating whether executives intentionally obscured the company's true risk profile to manipulate market perception. Investors seeking to participate as lead plaintiffs must act before the October deadline, though the firm notes that individual recovery remains possible for all eligible shareholders regardless of lead status.
Comments (0)
No comments yet. Be the first!